Brief: Xbrane Biopharma Q4 EBITDA SEK -23.2 Million

Xbrane Biopharma AB

20/02/2025 07:00

Feb 20 (Reuters) - Xbrane Biopharma Q4 EPS SEK -0.03.
* Q4 revenue SEK 65.8 million
* Q4 net income SEK -53.2 million